News

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...
In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.
Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...
Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.
On top of the discomfort, vaginal itching can cause a lot of anxiety as you wonder what could be wrong, especially if it's ...
The intensity of CKD-aP is linked to levels of systemic inflammation, with reductions in these levels seen with difelikefalin treatment.
Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...
EU kicks off review of GSK's linerixibat in PBC. GSK's drug for severe itching in patients with autoimmune liver disease PBC is now under review in the EU and US, as Mirum Pharma tries to catch up.
Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 ...